Scientists release data on potential new treatment targets for malaria

May 19, 2010
Malaria is caused by the Plasmodium parasite, which is transmitted through the bite of an infected mosquito. Image shows malarial parasites (in green) infecting a red blood cell. Credit: St. Jude Children's Research Hospital

An international team led by St. Jude Children's Research Hospital investigators today released data detailing the effectiveness of nearly 310,000 chemicals against a malaria parasite that remains one of the world's leading killers of young children.

The research, which appears in the May 20 edition of the scientific journal Nature, identified more than 1,100 new compounds with confirmed activity against the . Of those, 172 were studied in detail, leading to identification of almost two dozen families of molecules investigators consider possible candidates for drug development. St. Jude researchers already used one of the molecules to stop the parasite's growth in mice.

The six-year project was launched by R. Kiplin Guy, Ph.D., St. Jude Department of and Therapeutics chair, in an effort to revive malaria drug development. Guy is senior author of the study. W. Armand Guiguemde, Ph.D., a postdoctoral fellow in Guy's laboratory, is the first author.

"Malaria causes roughly 8 percent of childhood deaths worldwide and remains among the greatest threats to children in the ," Guy said. "At St. Jude, we focus on diseases that kill children, but lack good treatments. That is what drove us to start this work."

"These are the same tools and techniques that we are now using to find new targets and drugs to treat childhood cancer. This work illustrates their enormous power for ," said Dr. William Evans, St. Jude director and chief executive officer.

The effort has grown into a consortium that includes investigators at nine institutions and foundations in the U.S., Australia and Europe. Collaborators are taking cooperation a step further and launching a public database to share the results of their research and the underlying data.

"We've provided a toolbox to the global community and given them a lot of the early results from working with the tools so they won't have to repeat the work," Guy said. "This new information doubles the number of chemical structures available for anti-malarial ."

The database includes the chemical structure and activity profile of each of the 309,474 molecules in the St. Jude library of drugs, natural compounds and other chemicals. There is additional information about the 172 compounds that were more comprehensively evaluated. The compounds are all commercially available. Researchers interested in accessing the database can visit www.stjuderesearch.org/guy/data/malaria.

In recent years, development has focused on creating medications against specific targets or on improving existing medications. The approach focused on a handful of chemical targets, and results have been disappointing.

For this study, investigators used a different strategy and surveyed the hospital's library of compounds looking for those effective against the entire malaria parasite. Scientists tested the chemicals against the Plasmodium falciparum, the deadliest of the malaria parasites. The work led St. Jude researchers to three families of molecules, including two believed to act against new targets. Investigators hope to have a new drug in the clinic within a decade.

Explore further: New hope in fight against muscular dystrophy

Provided by St. Jude Children's Research Hospital

5 /5 (2 votes)

Related Stories

Discovery provides new drug targets for malaria cure

Jan 11, 2010

Researchers are a step closer to developing new antimalarial drugs after discovering the normal function of a set of proteins related to the malaria parasite protein, which causes resistance to the front-line drug chloroquine. ...

Progress in understanding the malarial parasite

Sep 14, 2007

About 2 million people die of malaria every year, of which more than a million are children in sub-Saharan Africa. Malaria is caused by a protozoan parasite belonging to the genus Plasmodium, and Plasmodium falciparum is ...

Recommended for you

The impact of bacteria in our guts

12 hours ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

12 hours ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

13 hours ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 4

Adjust slider to filter visible comments by rank

Display comments: newest first

labtvonline
not rated yet May 19, 2010
It's pretty incredible that most people still don't realize how much havoc malaria currently reaps on the world populations. Especially in America, we rarely feel the impact of the disease but it is the worlds' deadliest, killing 1 to 3 million a year. Huge advancements are being made just like this one pretty consistently with this disease. I'll post a video that I feel will greatly enhance this article on the malaria disease.

http://www.ndep.u...-Malaria
fixer
1 / 5 (1) May 20, 2010
Well yes, and Artemisinin is the best drug for both Malaria and Cancer, but so what?
Unless you can stop people being bitten by Mossies you cannot prevent reinfection of malaria so any drug is worth squat!
Put your money into erradicating Mossies and you will not need drugs.
A little common sense please.
TJ_alberta
not rated yet May 20, 2010
fixer: good point but don't you mean that immunization would be more effective than a treatment for the disease, once established? Having both immunization and effective meds in the toolkit would seem ideal. Because of the target market both must be inexpensive but, on the other hand the market is large.
fixer
1 / 5 (1) May 20, 2010
Who would you immunise, the entire population of the world?
Malaria is carried by other species as well as humans so the only effective target is the Mosquito itself.
What's happening with that laser that was showcased hereabouts- http://www.physor...943.html
Does anyone follow up on these devices?
Prediction, laser mossie zappers backed up with Artemisinin or Sweet Annie tea- http://www.anamed...006.html
and Malaria would be erradicated within a year.
I wish the people who write these stories would read the posts we write!